EUVIMEDEUVIMED entdecken
Crossref

Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer

Miguel Ángel Gómez-Luque iD, Paula Rodríguez-Marcos iD, Rubén Campanario-Pérez iD, Antonio Medina-González iD, Alejandro Cárdenas-Fernández iD, Walter Orlandi-Oliveira iD, Manuel Ruibal-Moldes

The Prostate · 2026

DOI: 10.1002/pros.70088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2026. Verfasst von Miguel Ángel Gómez-Luque und 6 weiteren Autor:innen. Beteiligte Einrichtung: SUTURO Andalucia. SUTURO Urological Surgery, Seville, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Machine Learning, Precision Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Metastatic castration‐resistant prostate cancer (mCRPC) is an aggressive, lethal state of prostate cancer, for which early progression is an indicator of poor prognosis. The ability to predict this progression is of paramount clinical importance for guiding personalized treatment strategies. We aimed to develop and validate a novel machine learning (ML) model to predict early progression (≤ 12 months) to mCRPC and compare its performance against standard ML algorithms. Methods This was a retrospective analysis of 172 patients with mHSPC from the publicly available MSK‐IMPACT cohort. Inclusion criteria specified patients with mHSPC who had undergone genomic profiling and progressed to mCRPC during follow‐up. Patients with incomplete data were excluded. We collected 11 clinical, pathological, and genomic variables. The primary outcome was early progression (≤ 12 months) to mCRPC. Model performance was evaluated using a stratified fivefold cross‐validation, with AUC as the primary metric. Key Findings and Limitations A novel Rivality Index (RINH)‐based model, adapted from chemoinformatics, demonstrated significantly superior predictive performance (AUC: 0.86) compared to a panel of standard ML algorithms, none of which exceeded an AUC of 0.67. The model achieved an accuracy of 0.74, a sensitivity of 0.70, and a specificity of 0.77. Key limitations include the retrospective design and use of a single‐institution data set. Conclusions and Clinical Implications This novel RINH model offers a robust tool for risk stratification in mHSPC patients, capable of personalizing therapeutic strategies. However, external validation in multi‐center, prospective cohorts is an essential next step before its consideration as a clinical decision support tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantMachine LearningPrecision MedicineHumansMaleRetrospective StudiesDisease ProgressionAgedMiddle AgedPrognosis

Stichwörter der Autor:innen

castration‐resistant prostate cancercross‐validationmachine learningprecision oncologyprostate cancerrisk stratification

Autor:innen und Institutionen

  • SUTURO Andalucia. SUTURO Urological Surgery, Seville, Spain.
  • Foundation for Health Research Management in Seville (FISEVI), Seville, Spain.
  • Unit of Urology, San Juan de Dios del Aljarafe Hospital, Seville, Bormujos, Spain.
  • SUTURO Galicia. SUTURO Urological Surgery, Pontevedra, Bajo, Spain.

ORCID-Profile: Miguel Ángel Gómez-Luque, Paula Rodríguez-Marcos, Rubén Campanario-Pérez, Antonio Medina-González, Alejandro Cárdenas-Fernández, Walter Orlandi-Oliveira

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Gómez-Luque, M. Á., Rodríguez-Marcos, P., Campanario-Pérez, R., Medina-González, A., Cárdenas-Fernández, A., Orlandi-Oliveira, W., & Ruibal-Moldes, M. (2026). Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer. The Prostate. https://doi.org/10.1002/pros.70088

Vancouver

Gómez-Luque MÁ, Rodríguez-Marcos P, Campanario-Pérez R, Medina-González A, Cárdenas-Fernández A, Orlandi-Oliveira W, et al. Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer. The Prostate. 2026. doi:10.1002/pros.70088

BibTeX
@article{GmezLuque2026,
  author = {Gómez-Luque, Miguel Ángel and Rodríguez-Marcos, Paula and Campanario-Pérez, Rubén and Medina-González, Antonio and Cárdenas-Fernández, Alejandro and Orlandi-Oliveira, Walter and Ruibal-Moldes, Manuel},
  title = {Towards Precision Oncology: A New Predictive Machine Learning Model for Early Progression to Castration Resistant Prostate Cancer},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70088}
}
Kostenlos starten →